BUW.F BIO-RAD LABS INC. B DL 1

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
1,594 EUR
Close of Nov 11, 2026
185.00 300.00
Market cap
EUR 8.07B
P/E
9.0x
P/B
1.18x
ROE
5.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BUW.F undervalued?

Graham number
Price1,594
Graham value2,316
Discount31.2%

BUW.F trades 31.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIO-RAD LABS INC. B DL 1 fundamental analysis

No fundamental analysis for BIO-RAD LABS INC. B DL 1 yet.

BIO-RAD LABS INC. B DL 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIO-RAD LABS INC. B DL 1

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins…

Full company profile